middle.news
Saluda opens a larger pain market while confronting its funding test
12:38pm on Friday 23rd of October, 2026 AEDT
•
Medical Devices
Read Story
Saluda opens a larger pain market while confronting its funding test
12:38pm on Friday 23rd of October, 2026 AEDT
Key Points
US$90.2 million FY26 revenue, up 28%
Gross margin rises 230 basis points to 48.9%
US$116.0 million used in operating cash
CAP24 approval opens an estimated US$670 million US market segment
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Saluda Medical, (ASX:SLD)
OPEN ARTICLE